$CTABF News
Last published 4y ago
- 4y agoCTABFCANNTAB ANNOUNCES ITS ENTRANCE INTO THE NOVA SCOTIA CANNABIS MARKETPR NewswireTORONTO, Aug. 22, 2022 /PRNewswire/ - Canntab Therapeutics Limited (CSE:PILL) (OTCQB:CTABF) (FRA: TBF1) (the "Company" or "Canntab") a leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to provi
- 4y agoCTABFCANNTAB ANNOUNCES APPOINTMENT OF RICHARD GOLDSTEIN AS INTERIM CEOPR NewswireTORONTO, Aug. 2, 2022 /PRNewswire/ - Canntab Therapeutics Limited (CSE:PILL)(OTCQB:CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic application, announces that i
- 4y agoCTABFCanntab Corporate UpdatePR NewswireTORONTO, June 30, 2022 /PRNewswire/ - Canntab Therapeutics Limited (CSE:PILL) (OTCQB:CTABF) (FRA: TBF1) (the "Company" or "Canntab") a leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is providing a corp
- 4y agoCTABFCANNTAB ANNOUNCES CHANGE OF AUDITORPR NewswireTORONTO, May 30, 2022 /PRNewswire/ - Canntab Therapeutics Limited (CSE:PILL) (OTCQB:CTABF) (FRA: TBF1) (the "Company" or "Canntab") a leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, announces that that
- 4y agoCTABFCanntab Engages Hamish Sutherland as Strategic AdvisorPR NewswireTORONTO, April 13, 2022 /PRNewswire/ - Canntab Therapeutics Limited (CSE:PILL) (OTCQB:CTABF) (FRA: TBF1) (the "Company" or "Canntab") a leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to anno
- 4y agoCTABFCANNTAB SIGNS AFFILIATE AGRREMENT WITH ONPHARM-UNITEDPR NewswireSigns Affiliate Program with OnPharm-United with over 600 pharmacies in Ontario Receives approval from the Province of Saskatchewan to begin sales TORONTO, March 23, 2022 /PRNewswire/ - Canntab Therapeutics Limited ((PILL) ((CTABF) (FRA: TBF1.F) (th
- 4y agoCTABFCANNTAB SIGNS HISTORIC AGREEMENT WITH FIRST NATIONS GROWERS GP INC. TO ADDRESS THE OPIATE AND ILLICIT DRUG CRISIS AFFECTING INDIGENOUS PEOPLES THROUGHOUT CANADAPR NewswireTORONTO, Feb. 7, 2022 /PRNewswire/ - Canntab Therapeutics Limited (CSE:PILL) (OTCQB:CTABF) (FRA:TBF1) (the "Company" or "Canntab"), a leading innovator of cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to announ
- 4y agoCTABFCANNTAB ANNOUNCES CLOSING OF CONVERTIBLE DEBENTURE PRIVATE PLACEMENT, WARRANT EXPIRY EXTENSION AND CORPORATE UPDATEPR NewswireTORONTO, Feb. 1, 2022 /PRNewswire/ -- Canntab Therapeutics Limited ("Canntab" or the "Company") (CSE:PILL) (OTCQB:CTABF) (FRA:TBF1), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to an
- 4y agoCTABFCANNTAB OFFICIALLY LAUNCHES ITS ONLINE E-COMMERCE PLATFORMPR NewswireTORONTO, Jan. 20, 2022 /PRNewswire/ - Canntab Therapeutics Limited (CSE:PILL) (OTCQB:CTABF) (FRA: TBF1) (the "Company" or "Canntab"), a leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to ann
- 4y agoCTABFLVTTFLevitee Labs Partners with Canntab Therapeutics to Provide Alternatives to OpioidsGlobeNewswireThe agreement is anticipated to contribute to correcting the opioid crisis in Canada and serve as a foundation for both companies to potentially expand into new verticals in the future Levitee Labs and Canntab Therapeutics have executed a services agre
- 4y agoCTABFCANNTAB DELIVERS 1st SHIPMENT TO THE ONTARIO CANNABIS STORE AND 2nd SHIPMENT TO AUSTRALIAPR NewswireTORONTO, Jan. 10, 2022 /PRNewswire/ - Canntab Therapeutics Limited ((PILL) ((CTABF) (FRA:TBF1.F) (the "Company" or "Canntab"), a leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to provi
- 4y agoCTABFCANNTAB ENTERS INTO STRATEGIC PARTNERSHIP TO PROVIDE ALTERNATIVES TO OPIATES THROUGH LEVITEE CLINICSPR NewswireAgreement with Levitee to service over 35,000 annual patient visits with the aim to help treat their patients with substance use addictions and chronic pain Levitee Labs will offer the entire Canntab product lineup throughout all its clinics and
- 5y agoCTABFCanntab Receives Medical Sales Licence from Health CanadaPR NewswireTORONTO, Nov. 11, 2021 /PRNewswire/ - Canntab Therapeutics Limited (CSE:PILL) (OTCQB:CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to
- 5y agoCTABFCanntab Reaches Agreement with Innovative Bioinformatics Company, 36eight Technologies Inc.PR NewswireTORONTO, Oct. 18, 2021 /PRNewswire/ - Canntab Therapeutics Limited (CSE:PILL) (OTCQB:CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to
- 5y agoAGNPFALTCBDHFCBGZF+29Proactive news headlines including Kintara Therapeutics, NEXE Innovations, LexaGene Holdings and Mindset PharmaGlobeNewswireNew York , June 03, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies: Kintara Therapeutics Inc (NASDAQ:KTRA) (FRA:3D
- 5y agoCTABFCanntab Announces the Early Exercise of $1,259,250 WarrantsPR NewswireTORONTO, June 3, 2021 /PRNewswire/ - Canntab Therapeutics Limited (CSE:PILL) (OTCQB:CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to a